HSE’s CardioLife Test Among Winners of Data Fusion Awards 2026
The CardioLife genetic test—a development by the Centre for Biomedical Research and Technologies of the AI and Digital Science Institute at HSE University’s Faculty of Computer Science—has won the All-Russian cross-industry Data Fusion Awards, which recognise achievements in data and AI technologies. The project took first place in the Science–Business Partnership category, demonstrating a successful model for transferring technology from university research into the real healthcare sector.
The uniqueness of the test lies in its combination of next-generation sequencing methods (NGS) and artificial intelligence technologies. Unlike standard PCR tests and targeted panels, CardioLife can detect not only known hereditary variants but also previously unidentified somatic mutations in each individual patient. This ensures the most comprehensive and accurate diagnosis of predisposition to cardiovascular diseases. The awards jury highly praised not only the test’s current capabilities but also its potential for advancing personalised cardiology and supporting import substitution in high-tech diagnostics.
A Technology Aimed at the Future
Unlike conventional PCR tests, CardioLife is a ‘living’ technology capable of evolving. By using next-generation sequencing (NGS) and AI algorithms, the test not only records known mutations but also identifies new hereditary and somatic variants, adapting to the data of each specific patient.
The developers position CardioLife as a platform solution that will continue to improve as more data is accumulated and as the needs of the medical community evolve. At present, the test covers a wide range of conditions, from Brugada syndrome and catecholaminergic tachycardia to familial hypercholesterolaemia, aortic aneurysms, and thrombophilia.
‘CardioLife is not just a test—it is an intelligent system. We set out to create a product that would continuously learn and expand its capabilities. Winning the Data Fusion Awards signals that the industry supports this very approach: deep science, advanced technologies, and, most importantly, a focus on real clinical practice. We see a future where such tests become the standard for preventing sudden cardiac death,’ commented Maria Poptsova, Director of the Centre for Biomedical Research and Technologies at the AI and Digital Science Institute, HSE University.
Partnership as a Driver of Innovation
The development is being carried out in close collaboration with industry partners—Evogen and Genotek—which are testing and adapting the product for the broader market. Cooperation based on licensing HSE University’s developments has made it possible to significantly accelerate the creation of product prototypes and test them in real market conditions. This model helps strike a balance between business interests and the research agenda of the scientific team.
‘For us, partnership with HSE University is a prime example of how science and business can work together to create truly in-demand medical solutions. CardioLife combines deep scientific expertise with practical value, which is particularly important for integrating genetic technologies into clinical practice. We see great potential for this product in the personalised medicine market and are actively involved in its development and scaling,’ said Alexander Rakitko, Director of Science at Genotek.
‘Evogen has long collaborated with colleagues from the AI and Digital Science Institute at HSE University, and these are always fascinating, science-intensive projects. The CardioLife product is personally meaningful to me, as my primary specialisation is cardiology, and I was delighted to contribute to bringing it to market. I am very pleased that it has received such high recognition at the Data Fusion competition,’ said Olesya Sagaidak, Deputy CEO of Evogen.
For patients, taking the test offers not only insight into genes associated with cardiovascular diseases but also the opportunity to significantly improve both quality and length of life through preventive measures. Medical centres implementing CardioLife gain a tool for a personalised approach based on precise genomic data. This helps build long-term relationships with patients, who return for preventive check-ups and ongoing health monitoring. The creators plan to further refine the test by expanding the number of detectable conditions in response to the current needs of the medical community.
This prestigious award recognises the commercial potential of the CardioLife product. HSE University’s collaboration with companies developing cutting-edge diagnostic services based on genetic technologies enables the introduction of a wide range of products to the market—both for clinical use and for a broader audience seeking personalised prevention and health management programmes. The strong scientific reputation of researchers at one of Russia’s leading universities increases trust in such innovative products and contributes to improving the quality of medical services.
See also:
Preserving Rationality in a Period of Turbulence
The HSE International Laboratory for Logic, Linguistics and Formal Philosophy studies logic and rationality in a transformed world characterised by a diversity of logical systems and rational agents. The laboratory supports and develops academic ties with Russian and international partners. The HSE News Service spoke with the head of the laboratory, Prof. Elena Dragalina-Chernaya, about its work.
Resource Race and Green Transition: Three Unexpected Conclusions from Foresight Centre’s Research on Climate and Poverty
Beneath the surface of green energy—which most people associate with solar panels, electric vehicles, and reduced CO2 emissions—lies a complex web of geopolitical interests, international inequality, and resource constraints. Researchers from the Laboratory for Science and Technology Studies (LST) at the HSE ISSEK Foresight Centre have published a series of articles in leading international journals on hidden and overt conflicts surrounding critically important metals and minerals, as well as related processes in the energy sector.
HSE Students Among Winners of Yandex High-Tech Startup Accelerator
Yandex has announced the results of its Yandex AI Startup Lab accelerator, whose final round featured 12 IT projects. Over the course of three months, their creators—students and young entrepreneurs—worked alongside the company’s experts to develop their products. Four startups in digital marketing, medicine, and robotics were named the best, with their teams receiving cash prizes and cloud resource grants. Among them was Gradius, a startup founded by students from HSE University.
‘Any Real-Economy Company Can Use Our Products’
The HSE Centre for Financial Research and Data Analytics combines fundamental and applied work, including in areas unique to Russia such as the connection between sentiment in the media and social networks and financial markets. The HSE News Service spoke with the centre’s director, Professor Tamara Teplova, about its work.
Researchers Find More Effective Approach to Revealing Majorana Zero Modes in Superconductors
An international team of researchers, including physicists from HSE MIEM, has demonstrated that nonmagnetic impurities can help more accurately reveal Majorana zero modes—quantum states considered promising building blocks for quantum computing. The researchers found that these impurities shift the energy levels that typically obscure the Majorana signal, while leaving the mode itself largely unaffected, thereby making its spectral peak more distinct. The study has been published in Research.
New Development by HSE Scientists Helps Design Reliable Electronics Faster at a Lower Cost
Scientists from HSE MIEM have developed a new approach to modelling electrothermal processes in high-power electronic circuits on printed circuit boards (PCB). The method allows engineers to quickly and accurately predict how electronic components heat up during operation, helping prevent overheating and potential failures. The results have been published in Russian Microelectronics.
'Where Accurate Prediction of the Outcome Is Impossible, Stochastic Methods Come into Play'
The Laboratory of Stochastic Analysis and its Applications at HSE University studies systems and events in which randomness plays a central role. The goal is to predict various phenomena and how they evolve over time. The HSE News Service interviewed the laboratory's head Vladimir Panov and its academic supervisor Valentin Konakov.
Mathematical Physics at HSE University Goes International
The HSE University International Laboratory for Mirror Symmetry and Automorphic Forms and the Beijing Institute of Mathematical Sciences and Applications (BIMSA) held a joint online conference on mathematical physics. The results of the laboratory research presented at the event will be published in leading academic journals.
HSE Biologists Identify Factors That Accelerate Breast Cancer Recurrence
Scientists at HSE University have identified a molecular mechanism underlying aggressive breast cancer. They found that the signals supporting tumour growth originate not from the tumour itself but from its microenvironment. The researchers also demonstrated that reduced levels of the IGFBP6 protein in the tumour microenvironment lead to the accumulation of macrophages—immune cells associated with a higher risk of cancer recurrence. These findings already make it possible to assess patient risk more accurately and may, in the future, enable the development of drugs that target cells of the tumour microenvironment. The study has been published in Current Drug Therapy.
HSE University and Moscow DIT Partner to Advance 5G and 6G Networks
The Moscow Department of Information Technology and HSE University have signed a cooperation agreement in the field of innovative development of the capital’s IT infrastructure. The parties agreed on joint research into modern and promising communication technologies, including 5G and 6G, as well as AI, the Internet of Things, and other smart city technologies.